Anna Ida Fiaschi Selected Research

Anna Ida Fiaschi Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 01/2008
6	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 12/2008
5	Disease Progression 01/2020 - 04/2015
4	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 03/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015 - 01/2003
2	Neutropenia 01/2020 - 04/2015
2	Cardiotoxicity 10/2017 - 01/2007
2	Stomach Neoplasms (Stomach Cancer) 08/2016 - 01/2008
2	Neoplasm Metastasis (Metastasis) 06/2011 - 12/2008
1	Adenocarcinoma 08/2020
1	Diarrhea 01/2020
1	Anemia 01/2020
1	Necrosis 01/2019
1	Inflammation (Inflammations) 01/2019
1	Varicocele 01/2019
1	Hand-Foot Syndrome 12/2018
1	Ovarian Epithelial Carcinoma 09/2015
1	Ovarian Neoplasms (Ovarian Cancer) 09/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015
1	Thrombocytopenia (Thrombopenia) 04/2015
1	Chronic Renal Insufficiency 12/2014
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 10/2014
1	Bone Resorption 06/2011
1	Hyperthermia 08/2010
1	Breast Neoplasms (Breast Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 03/2010
5	Capecitabine (Xeloda)FDA Link 01/2020 - 01/2008
4	Abiraterone AcetateIBA 09/2015 - 04/2014
3	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2003
3	Bevacizumab (Avastin)FDA Link 12/2018 - 04/2015
3	Epirubicin (Ellence)FDA LinkGeneric 09/2015 - 12/2008
3	Fluorouracil (Carac)FDA LinkGeneric 09/2015 - 10/2002
2	Leucovorin (Folinic Acid)FDA Link 09/2015 - 10/2002
2	Gemcitabine FDA Link 04/2015 - 04/2015
1	CB2 Cannabinoid ReceptorIBA 08/2020
1	CannabinoidsIBA 08/2020
1	CannabidiolIBA 08/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	Dronabinol (THC)FDA LinkGeneric 08/2020
1	CytokinesIBA 01/2019
1	CatalaseIBA 01/2019
1	Annexin A5IBA 01/2019
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2019
1	Propidium (Propidium Iodide)IBA 01/2019
1	ResistinIBA 01/2019
1	AdipokinesIBA 01/2019
1	regorafenibIBA 12/2018
1	Cocaine (Cocaine HCl)IBA 10/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 08/2016
1	apatinibIBA 08/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015
1	Carboplatin (JM8)FDA LinkGeneric 09/2015
1	Methotrexate (Mexate)FDA LinkGeneric 09/2015
1	taxaneIBA 09/2015
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 09/2015
1	cabazitaxel FDA Link 09/2015
1	Vinblastine (Vinblastine Sulfate)FDA Link 09/2015
1	Prednisone (Sone)FDA LinkGeneric 05/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2015
1	Cisplatin (Platino)FDA LinkGeneric 04/2015
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	abirateroneIBA 04/2014
1	Zoledronic Acid (Zometa)FDA Link 06/2011
1	collagen type I trimeric cross-linked peptideIBA 06/2011
1	Alkaline PhosphataseIBA 06/2011
1	Ibandronic Acid (Boniva)FDA Link 06/2011
1	Collagen Type I (Type I Collagen)IBA 06/2011
1	Free RadicalsIBA 08/2010
1	Biological ProductsIBA 08/2010
1	Thymidine PhosphorylaseIBA 03/2010
1	Thymidylate SynthaseIBA 03/2010
1	Hormones (Hormone)IBA 12/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2008
1	CatecholaminesIBA 01/2007
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2007
1	Antineoplastic Agents (Antineoplastics)IBA 01/2003
1	AnthracyclinesIBA 10/2002
1	Taxoids (Taxanes)IBA 10/2002
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2020 - 10/2002
5	Therapeutics 01/2020 - 01/2015
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 09/2015
2	Maintenance Chemotherapy 01/2020 - 09/2015
2	Castration 09/2015 - 12/2014
1	Salvage Therapy 09/2015
1	Induction Chemotherapy 04/2015